Suppr超能文献

鉴定枝顶孢属中的 14-α-羊毛甾醇脱甲基酶(CYP51)。

Identification of 14-α-Lanosterol Demethylase (CYP51) in Scedosporium Species.

机构信息

Mycotic and Parasitic Agents and Mycobacteria, Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany.

Molecular Mycology Research Laboratory, Centre for Infectious Diseases and Microbiology, Sydney Medical School, The University of Sydney, Westmead Hospital, Westmead Institute for Medical Research, Westmead, Australia.

出版信息

Antimicrob Agents Chemother. 2018 Jul 27;62(8). doi: 10.1128/AAC.02599-17. Print 2018 Aug.

Abstract

spp. cause infections (scedosporiosis) in both immunocompetent and immunocompromised individuals and may persistently colonize the respiratory tract in patients with cystic fibrosis (CF). They are less susceptible against azoles than are other molds, such as spp., suggesting the presence of resistance mechanisms. It can be hypothesized that the decreased susceptibility of spp. to azoles is also CYP51 dependent. Analysis of the and genomes revealed one gene encoding the 14-α-lanosterol demethylase. This gene from 159 clinical or environmental isolates and three isolates has been sequenced and analyzed. The CYP51 protein clustered with the group of known CYP51B orthologues and showed species-specific polymorphisms. A tandem repeat in the 5' upstream region of like that in could not be detected. Species-specific amino acid alterations in CYP51 of , , , and isolates were located at positions that have not been described as having an impact on azole susceptibility. In contrast, two of the three specific amino acid changes (Y136F and G464S) corresponded to respective mutations in CYP51A at amino acid positions 121 and 448 (Y121F and G448S, respectively) that had been linked to azole resistance.

摘要

spp. 可引起免疫功能正常和免疫功能低下个体的感染(鞘内菌病),并可能在囊性纤维化(CF)患者的呼吸道中持续定植。与其他霉菌(如 spp.)相比,它们对唑类药物的敏感性较低,这表明存在耐药机制。可以假设, spp. 对唑类药物的敏感性降低也与 CYP51 有关。对 和 基因组的分析揭示了一个编码 14-α-羊毛甾醇脱甲基酶的 基因。已对来自 159 个临床或环境 分离株和 3 个 分离株的该基因进行了测序和分析。CYP51 蛋白与已知 CYP51B 直系同源物的组聚类,并显示出种特异性多态性。在 5' 上游区域的串联重复,如在 中那样,无法检测到。 、 、 和 分离株的 CYP51 中的种特异性氨基酸改变位于尚未描述为对唑类药物敏感性有影响的位置。相比之下,三个特定氨基酸变化中的两个(Y136F 和 G464S)与 CYP51A 中的相应突变相对应,该突变位于氨基酸位置 121 和 448(分别为 Y121F 和 G448S),已与唑类药物耐药性相关。

相似文献

1
Identification of 14-α-Lanosterol Demethylase (CYP51) in Scedosporium Species.
Antimicrob Agents Chemother. 2018 Jul 27;62(8). doi: 10.1128/AAC.02599-17. Print 2018 Aug.
2
CYP51 Paralogue Structure Is Associated with Intrinsic Azole Resistance in Fungi.
mBio. 2021 Oct 26;12(5):e0194521. doi: 10.1128/mBio.01945-21. Epub 2021 Oct 5.
3
Impact of Homologous Resistance Mutations from Pathogenic Yeast on Saccharomyces cerevisiae Lanosterol 14α-Demethylase.
Antimicrob Agents Chemother. 2018 Feb 23;62(3). doi: 10.1128/AAC.02242-17. Print 2018 Mar.
4
Antifungal Susceptibility Profiles and Drug Resistance Mechanisms of Clinical Lomentospora prolificans Isolates.
Antimicrob Agents Chemother. 2020 Oct 20;64(11). doi: 10.1128/AAC.00318-20.
6
First Detection of TR34 L98H and TR46 Y121F T289A Cyp51 Mutations in Aspergillus fumigatus Isolates in the United States.
J Clin Microbiol. 2016 Jan;54(1):168-71. doi: 10.1128/JCM.02478-15. Epub 2015 Oct 21.
7
Point Mutation or Overexpression of Aspergillus fumigatus Encoding Lanosterol 14α-Sterol Demethylase, Leads to Triazole Resistance.
Antimicrob Agents Chemother. 2021 Sep 17;65(10):e0125221. doi: 10.1128/AAC.01252-21. Epub 2021 Jul 26.

引用本文的文献

1
The Significance of Mono- and Dual-Effective Agents in the Development of New Antifungal Strategies.
Chem Biol Drug Des. 2025 Jan;105(1):e70045. doi: 10.1111/cbdd.70045.
2
Scedosporiosis and lomentosporiosis: modern perspectives on these difficult-to-treat rare mold infections.
Clin Microbiol Rev. 2024 Jun 13;37(2):e0000423. doi: 10.1128/cmr.00004-23. Epub 2024 Mar 29.
4
A Cyp51B Mutation Contributes to Azole Resistance in .
J Fungi (Basel). 2020 Nov 26;6(4):315. doi: 10.3390/jof6040315.
5
Antifungal Susceptibility Profiles and Drug Resistance Mechanisms of Clinical Lomentospora prolificans Isolates.
Antimicrob Agents Chemother. 2020 Oct 20;64(11). doi: 10.1128/AAC.00318-20.
6
The Fungal CYP51s: Their Functions, Structures, Related Drug Resistance, and Inhibitors.
Front Microbiol. 2019 Apr 24;10:691. doi: 10.3389/fmicb.2019.00691. eCollection 2019.

本文引用的文献

1
Scedosporium and Lomentospora: an updated overview of underrated opportunists.
Med Mycol. 2018 Apr 1;56(suppl_1):102-125. doi: 10.1093/mmy/myx113.
2
Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013).
Diagn Microbiol Infect Dis. 2016 Jun;85(2):200-4. doi: 10.1016/j.diagmicrobio.2016.02.009. Epub 2016 Feb 9.
3
First Detection of TR34 L98H and TR46 Y121F T289A Cyp51 Mutations in Aspergillus fumigatus Isolates in the United States.
J Clin Microbiol. 2016 Jan;54(1):168-71. doi: 10.1128/JCM.02478-15. Epub 2015 Oct 21.
4
Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?
Clin Infect Dis. 2016 Feb 1;62(3):362-8. doi: 10.1093/cid/civ885. Epub 2015 Oct 20.
5
Cluster analysis of Scedosporium boydii infections in a single hospital.
Int J Med Microbiol. 2015 Oct;305(7):724-8. doi: 10.1016/j.ijmm.2015.08.024. Epub 2015 Aug 24.
6
Environmental isolates of azole-resistant Aspergillus fumigatus in Germany.
Antimicrob Agents Chemother. 2015 Jul;59(7):4356-9. doi: 10.1128/AAC.00100-15. Epub 2015 May 4.
9
Draft Genome Sequence of the Pathogenic Fungus Scedosporium apiospermum.
Genome Announc. 2014 Oct 2;2(5):e00988-14. doi: 10.1128/genomeA.00988-14.
10
Molecular typing of clinical Cryptococcus neoformans isolates collected in Germany from 2004 to 2010.
Med Microbiol Immunol. 2014 Oct;203(5):333-40. doi: 10.1007/s00430-014-0341-6. Epub 2014 May 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验